Male and Female Stem Cells Derived from One Donor in Scientific First
By Dan Robitzski,
The Scientist
| 12. 22. 2022
Scientists have developed a new line of stem cells—all derived from the same person—that can be used to study sex differences without the confounds of interpersonal genetic differences.
Human induced pluripotent stem cells (hiPSCs), which are cells taken from a person that are then reprogrammed to abandon their current roles and return to a stem cell–like state, have become valuable tools not only for therapeutic purposes but also for probing the genetic mechanisms underlying cell behavior and disease. However, findings drawn from stem cell studies may not be broadly applicable, as the fact that all cells in a given line share the same genetic sequence makes it difficult to generalize discoveries, especially when it comes to investigating potential sex differences.
That’s why a team of scientists led by Benjamin Reubinoff, an embryonic stem cell researcher at the Hadassah Medical Organization in Jerusalem, and MD-PhD student Ithai Waldhorn set out to create a new platform for studying genetic sex differences. As Reubinoff tells The Scientist, “The origin was really to generate a model for studying sex differences, given the...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...